BTW
VIVO

Boston Trust Walden’s Meridian Bioscience Inc VIVO Stock Holding History

Boston Trust Walden’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-705,936
Closed -$10.1M – 391
2017
Q3 		$10.1M Sell
705,936
-3,427
-0.5% -$49K 0.16% 179
2017
Q2 		$11.2M Sell
709,363
-226,227
-24% -$3.26M 0.18% 160
2017
Q1 		$12.9M Sell
935,590
-93,363
-9% -$1.31M 0.2% 159
2016
Q4 		$18.2M Sell
1,028,953
-63,382
-6% -$1.11M 0.29% 132
2016
Q3 		$21.1M Sell
1,092,335
-1,525
-0.1% -$29.8K 0.35% 114
2016
Q2 		$21.3M Sell
1,093,860
-4,853
-0.4% -$95.2K 0.36% 104
2016
Q1 		$22.6M Buy
1,098,713
+240,840
+28% +$4.75M 0.39% 94
2015
Q4 		$17.6M Buy
+857,873
New +$16.4M 0.33% 124
2014
Q3 		– Sell
-1,209,346
Closed -$25M – 345
2014
Q2 		$25M Buy
1,209,346
+14,747
+1% +$303K 0.36% 125
2014
Q1 		$26M Sell
1,194,599
-22,054
-2% -$505K 0.39% 119
2013
Q4 		$32.3M Sell
1,216,653
-83,015
-6% -$2.04M 0.47% 95
2013
Q3 		$30.7M Sell
1,299,668
-22,654
-2% -$529K 0.47% 98
2013
Q2 		$28.4M Buy
+1,322,322
New +$28.5M 0.46% 103

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

Boston Trust Walden's VIVO Position: Q4 2017 in Review

Boston Trust Walden sold out of Meridian Bioscience Inc (VIVO) in Q4 2017, closing a stake of 705,936 shares — an estimated $10.1M sold.

Boston Trust Walden first reported a position in VIVO in Q2 2013 and held it in 13 quarters. The position peaked at $32.3M in Q4 2013. 178 funds tracked by Wall St. Rank hold VIVO as of Q4 2017.

  • Boston Trust Walden reported no remaining Meridian Bioscience Inc position as of Q4 2017 after selling out during the quarter.
  • Boston Trust Walden sold 705,936 Meridian Bioscience Inc shares in Q4 2017, an estimated $10.1M.
  • Boston Trust Walden first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 13 quarters.
  • Boston Trust Walden's Meridian Bioscience Inc position peaked at $32.3M in Q4 2013.
  • 178 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2017.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.